Trial intelligence / Profile preview

Piboserod in Symptomatic Congestive Heart Failure

NCT00421746Phase 2Completed

Sponsor
Bio-Medisinsk Innovasjon AS
Start
Jan 2006
Modality
Small Molecules
Countries
3
01

Overview

A Phase 2 trial of piboserod in heart failure (HF), sponsored by Bio-Medisinsk Innovasjon AS. Started Jan 2006; status: completed.

02

Drugs

piboserod
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00421746.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00421746.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call